Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
LUDWIG ENTERPRISES, INC.
SIC 8071 · Services-Medical Laboratories
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
LUDWIG ENTERPRISES, INC.
SIC 8071 · Services-Medical Laboratories
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
LUDWIG ENTERPRISES, INC.
SIC 8071 · Services-Medical Laboratories
Notes
Support
about
terms
$
LUDG
LUDWIG ENTERPRISES, INC.
CIK:
0001960262
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.26.1
Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]
Revenues
Operating expenses
General and administration expenses
555,679
450,687
Research and development
9,300
74,234
Total operating expenses
564,979
524,921
Net loss from operations
(564,979)
(524,921)
Other income (expense)
Interest income
2,000
Other income
2,333
Interest expense
(91,552)
(20,355)
Change in fair value of warrant liability
(25,000)
Change in fair value of derivative liability
46,585
Amortization of debt discount
(146,207)
Gain on equity securities exchange
825,000
Unrealized gain on marketable security
175,000
Total other income (expense)
783,826
(16,022)
Net income (loss) before taxes
218,847
(540,943)
Income tax benefit
Net income (loss)
$ 218,847
$ (540,943)
Basic income (loss) per common share (in Dollars per share)
$ 0
$ 0
Diluted income (loss) per common share (in Dollars per share)
$ 0
$ 0
Weighted average number of common shares outstanding, basic (in Shares)
163,591,383
161,182,240
Weighted average number of common shares outstanding, diluted (in Shares)
864,591,383
161,182,240
v3.26.1
Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows from Operating Activities:
Net income (loss)
$ 218,847
$ (540,943)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Stock issued for services
166,372
Stock issued for settlement of claims
179,286
Reversal of previously recognized stock-based compensation
(38,622)
Interest income
(2,000)
Amortization of debt discount
146,207
Change in fair value of warrant liability
25,000
Change in fair value of derivative liability
(46,585)
Gain on equity securities exchange
(825,000)
Unrealized gain on marketable security
(175,000)
Changes in operating assets and liabilities:
Prepaid expenses
11,161
9,220
Accounts payable and accrued liabilities
352,047
277,789
Net Cash Used in Operating Activities
(152,659)
(89,562)
Cash Flows from Financing Activities:
Deferred offering cost
(9,883)
(52,767)
Proceeds from related party
52,159
Repayments to related party
(17,883)
Proceeds from convertible notes payable - net
200,000
100,000
Repayment the bank overdraft
(1,252)
Net Cash Provided by Financing Activities
170,982
99,392
Net change in cash
18,323
9,830
Cash, beginning of period
6,741
Cash, end of period
18,323
16,571
Supplemental cash flow information:
Cash paid for interest
12,768
5,000
Cash paid for taxes
Supplemental disclosure of non-cash financing activity:
Recognition of warrant liability
126,000
Exchange of 2,500,000 shares of LMMY common stock in exchange for MAJI preferred shares
$ 825,000
v3.26.1
Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current Assets
Cash
$ 18,323
Inventory
4,529
4,529
Prepaid expenses
3,720
14,881
Deferred offering cost
122,834
112,951
Note receivable
106,000
106,000
Total Current Assets
255,406
238,361
Other investment
1,000,000
Intangible assets, net of accumulated
9,166
9,166
Total Assets
1,264,572
247,527
Current Liabilities
Bank overdraft
1,252
Accounts payable and accrued liabilities
1,954,852
1,602,805
Notes payable
1,270,009
1,270,009
Convertible notes payable, net
1,391,620
1,171,413
Warrant liability
151,000
Derivative liability
488,874
535,459
Total Current Liabilities
5,293,267
4,635,733
Total Liabilities
5,293,267
4,635,733
Stockholders’ Deficit
Preferred stock: 7,000,000 authorized; $0.001 par value, 7,000,000 shares issued and outstanding
7,000
7,000
Common stock: 1,250,000,000 authorized; $0.001 par value, 167,166,897 and 162,569,807 shares issued and outstanding, respectively
167,165
162,568
Additional paid in capital
5,074,092
4,938,025
Accumulated deficit
(9,276,952)
(9,495,799)
Total Stockholders’ Deficit
(4,028,695)
(4,388,206)
Total Liabilities and Stockholders’ Deficit
1,264,572
247,527
Related Party
Current Liabilities
Due to related party
$ 36,912
$ 54,795